Lung cancer
Evaluation of low dose immunotherapy for lung cancer
Who can joinAdults
Age18–75 years
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHINew Delhi, DelhiDirections ↗
Registry summary (technical)
Evaluation of low dose nivolumab with neoadjuvant chemotherapy in non small cell lung cancer - ELoN
Sponsor: Indian Council of Medical Research
CTRI/2023/02/050126 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 27 Apr 2026 · read by us 5 Nov 2026